Benefits and resource implications of family meetings for hospitalized palliative care patients: research protocol. by Hudson, Peter L. et al.
Benefits and resource implications of family meetings for
hospitalized palliative care patients: research protocol.
Hudson, P. L., Girgis, A., Mitchell, G. K., Philip, J., Parker , D., David, C., ... Brand, C. (2015). Benefits and
resource implications of family meetings for hospitalized palliative care patients: research protocol. BMC




Publisher's PDF, also known as Version of record
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
Publisher rights
© 2015 Hudson et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:15. Feb. 2017
STUDY PROTOCOL Open Access
Benefits and resource implications of family
meetings for hospitalized palliative care
patients: research protocol
Peter L. Hudson1,2*, Afaf Girgis3, Geoffrey K. Mitchell4, Jenny Philip1, Deborah Parker5, David Currow6, Danny Liew7,
Kristina Thomas1, Brian Le8, Juli Moran9 and Caroline Brand7,10
Abstract
Background: Palliative care focuses on supporting patients diagnosed with advanced, incurable disease; it is ‘family
centered’, with the patient and their family (the unit of care) being core to all its endeavours. However, approximately
30–50 % of carers experience psychological distress which is typically under recognised and consequently not addressed.
Family meetings (FM) are recommended as a means whereby health professionals, together with family carers and
patients discuss psychosocial issues and plan care; however there is minimal empirical research to determine the net
effect of these meetings and the resources required to implement them systematically.
The aims of this study were to evaluate: (1) if family carers of hospitalised patients with advanced disease (referred to a
specialist palliative care in-patient setting or palliative care consultancy service) who receive a FM report significantly
lower psychological distress (primary outcome), fewer unmet needs, increased quality of life and feel more prepared for
the caregiving role; (2) if patients who receive the FM experience appropriate quality of end-of-life care, as demonstrated
by fewer hospital admissions, fewer emergency department presentations, fewer intensive care unit hours, less
chemotherapy treatment (in last 30 days of life), and higher likelihood of death in the place of their choice and
access to supportive care services; (3) the optimal time point to deliver FM and; (4) to determine the cost-benefit
and resource implications of implementing FM meetings into routine practice.
Methods: Cluster type trial design with two way randomization for aims 1-3 and health economic modeling and
qualitative interviews with health for professionals for aim 4.
Discussion: The research will determine whether FMs have positive practical and psychological impacts on the
family, impacts on health service usage, and financial benefits to the health care sector. This study will also provide clear
guidance on appropriate timing in the disease/care trajectory to provide a family meeting.
Trial registration: Australian New Zealand Clinical Trials Registry ACTRN12615000200583 .
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Background
Acute hospitals provide end-of-life care to the majority of
people who die in Australia and many other countries [1].
Palliative care focuses on supporting patients diagnosed
with advanced, incurable disease. It is ‘family centered’,
with the patient and their family considered to be the unit
of care [2]. Given the significant burden associated with
caring for a dying relative, the World Health Organisation
(WHO) advocates that health care services focus on
enhancing family members’ quality of life [3]. Accordingly,
many nations have established standards and policies for
responding to the needs of family carers as well as patients
[4–6]. Despite these initiatives, patients with advanced
disease may be exposed to aggressive or futile treatment,
and approximately 50 % of carers experience psychological
distress, which is typically under-recognised [7].
Communication with patients and their family is a vital
element of palliative care. Information exchange, preparing
for discharge and assessing needs is recommended stand-
ard practice. Only when carers of patients with advanced
disease are well informed are they able to provide high
quality end-of-life care for their relative [8]. Inadequate
communication can have profound negative effects result-
ing in psychological distress due to unmet information
needs, lack of shared decision making and mistrust of
healthcare providers [9]. Open discussions between health
professionals and family carers are an effective way of
providing psychological support [10]. However, the quality
of communication can vary considerably and communica-
tion failures are the most common reason for complaints
in health care, with end-of-life care being no exception [1].
Interventions with family carers which focus on respond-
ing to needs and preparing them for their role have
produced demonstrable improvements in carer well-being
and sense of preparedness [11, 12], reduction of unmet
needs [11, 13–16], and carer burden and increased quality
of life and knowledge of patient symptoms [17]. Findings
from systematic reviews also demonstrate that structured
information from health professionals can reduce anxiety
[18]. The benefits of family carer involvement in discharge
planning have also been reported [19].
One of the most important clinical tools for healthcare
providers to facilitate communication for people with
advanced disease is a family meeting [20–22]. Family meet-
ings (also known as family conferences), are meetings
between the family carers, the patient (where possible) and
health care professionals, and are undertaken for multiple
purposes including psychosocial support, clarifying the
goals of care, discussing diagnosis, treatment, prognosis,
discharge planning and developing a plan of care for the
patient and carer [23]. Studies on family meetings in inten-
sive care units (ICUs) have demonstrated improvement in
communication [20, 24], decrease in carer burden [25],
and, importantly, reduction in length of stay [26]. Family
meetings in the ICU have also led to measurable benefits
including decreased post-traumatic stress disorder, anxiety
and depression [20, 27].
Family meetings are recommended as a core intervention
within the context of palliative care provision [28]. These
encounters, however, are not usually provided consistently
or systematically, nor are they conducted according to best
available evidence [29]. Moreover, the specific outcomes for
patients, family carers and health professionals associated
with conducing a family meeting within the palliative care
setting are underexplored.
Structured family meetings guidelines and pilot work
Hudson and colleagues developed clinical practice guide-
lines [30] for conducting Structured Family Meetings
(SFMs) for those patients referred to specialist palliative
care in hospitals.
The meetings are intended to take no longer than one
hour and should be conducted by health care professionals
with relevant training in facilitating such meetings. Hudson
and colleagues subsequently examined the feasibility and
effectiveness of the SFM clinical guidelines in an observa-
tional study using mixed methods evaluation [31]. The
following outcomes were demonstrated: (1) family carers
reported significant reductions in unmet needs; (2) family
carers reported that meetings were informative and useful;
(3) health professionals reported that the meetings were
well-facilitated and (4) family meeting facilitators (provided
with specific training to convene and conduct a family
meeting) reported that they were better equipped to facili-
tate the meetings. This study provided preliminary data on
the feasibility and acceptability of family meetings as a
means of identifying and addressing family concerns.
These findings require further testing in a larger sample,
using more robust research methods [31]. In addition, it
would be advantageous to explore patient outcomes, ascer-
tain any sustained longer term benefits of SFM for family
carers (focusing on distress) and discern the best time
(within the advanced disease trajectory) to conduct family
meetings.
In summary, whilst current guidelines advocate family
meetings be routinely conducted for all patients [28], these
encounters are typically neither consistently provided nor
conducted according to best available evidence. There is
therefore justification to further investigate, within a robust
research evaluative study design, the impacts and outcomes
of SFM for patients, carers and families and the barriers
and enablers that may influence effective implementation.
Given the major financial and resource implications of
SFM, we will also provide clear guidance on the appropri-
ate timing in the disease/care trajectory to provide a family
meeting.
The purpose of this project is to evaluate outcomes
for patients and family carers who attend a SFM and
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determine the cost and resource implications of imple-
menting SFM into standard practice for hospitalised
patients with advanced disease.
Our aims are:
1. To assess the short and longer term effect of SFM
on patient and family carer outcomes and determine
the most appropriate time point in a patient’s
advanced disease trajectory to provide a SFM.
2. To determine the cost-benefit and resource implica-
tions of implementing SFM meetings into routine
practice.
Methods
The following sections detail the methods for addressing
each of the project aims.
Aim 1
To assess the short and longer term effect of SFM on
patient and family outcomes and determine the most
appropriate time point in a patient’s disease trajectory to
provide a SFM.
Our alternative hypotheses for Aim 1 are:
 (H1) Family carers of hospitalised patients with
advanced disease (referred to a specialist palliative
care in-patient setting or palliative care consultancy
service) who receive a SFM will report significantly
lower psychological distress (primary outcome), fewer
unmet needs, increased quality of life and feeling more
prepared for the caregiving role.
 (H2) Patients who receive the SFM will experience
appropriate quality of end-of-life care, as demonstrated
by fewer hospital admissions, fewer emergency depart-
ment (ED) presentations, fewer intensive care unit
hours, less chemotherapy treatment (in last 30 days of
life), and higher likelihood of death in the place of the
person’s choice (in consultation with their caregivers)
and access to supportive care services.
 (H3) Patients and family carers who receive a SFM
earlier in their advanced disease trajectory (i.e further
way from death) will have more favourable outcomes
(as per outcomes listed in H1 and H2).
Research design
This study will randomise three participating sites: all
sites will collect baseline data (i.e. Time 1, 2 & 3 data)
for 6 months; then two of the three sites will deliver the
intervention. As such, one site will remain the control
site for the entire time and there will be before and after
measurements (with excellent baseline data collected
prospectively) for the two sites which will participate in
the intervention. As each site will have baseline data,
any differences between sites can be identified and, if
necessary, controlled for during the analyses. The inter-
vention recruitment period is longer than the control
period in the two intervention sites to ensure that the total
numbers of control and intervention participants are
approximately equivalent). This design was deemed the
most appropriate and feasible method for this type of
health service research, since randomisation by patient in
each service risks cross-group contamination within that
clinical setting. A conventional cluster trial or stepped-
wedge design is not feasible due to the significant number
of sites that would be required. Sites will be randomised
by an independent statistician via a random number
generation system.
Participants
Inclusion criteria for patients Hospitalised patients with
advanced, non-curable disease referred to a specialist
palliative care in-patient unit or palliative care consult-
ancy service for inpatients, who have a person (relative
or friend) whom they perceive to be their main support
person (i.e primary family carer), who are willing for the
research team to approach the family carer for potential
research participation and agreeable to have their med-
ical information shared with the family carer, if pertin-
ent, during the SFM. Exclusion criteria for patients:
Under 18; likely to die within 1 week (as assessed by
treating physician or senior nurse); unable to identify a
primary family carer, unable to provide informed
consent due to cognitive impairment or incapacity to
comprehend and speak English (as assessed by treating
physician, senior nurse or research assistant).
Inclusion criteria for family carers Nominated by the
patient as their primary support person and willing to
attend a SFM if allocated to the intervention arm.
Exclusion criteria for family carers Under 18; incap-
acity to understand or speak English; unable to provide in-
formed consent due to cognitive impairment (as assessed
by the research assistant); or not agreeable to being con-
sidered the primary family carer.
For the intervention phase, patients and family carers
who have already been involved in a formal family meeting
as part of routine specialist palliative care will be excluded
from participation. As part of routine data collection for
the study we will ask each participating site to record in
the medical record if a formal family meeting (ie specific
meeting set up to confirm plan of care) has occurred.
Procedure
Recruitment (see Fig. 1) will occur as soon as possible
(within 48 h) after the patient is admitted to the pallia-
tive care unit or seen by the consultancy service. The
Hudson et al. BMC Palliative Care  (2015) 14:73 Page 3 of 9
research assistant will screen the list of new admissions
to both the inpatient unit and the consultative team
daily and speak with the clinical team to check eligibility.
They will approach eligible patients in person within
48 h of admission to give patients a copy of the Plain
Language Statement and consent form and invite
patients to participate. Patients will need to consent to
their medical records being accessed and their medical
details being discussed at the family meeting (if well
enough and if allocated to the intervention group).
Patients will need to identify a family carer (as per
inclusion criteria) and provide consent for the research
assistant to contact them about the study. Patients will
not be required to provide any self-report data.
The research assistant will then phone the family carer
(or approach them in person at the hospital) to invite them
to participate within 72 h of patient admission (see Fig. 1).
The research assistant will give the family carer a copy of
the Plain Language Statement and consent form if
approaching them in person and go through it with them
and obtain formal written consent. If contact has been
made by phone, the research assistant will go through the
content of the Plain Language Statement and consent form
with them over them phone and send it to them (either by
email or post) to be signed and returned by post or in
person. Once the carer has consented, the research assist-
ant will arrange a convenient time (and place) to collect
time 1 data either over the phone or in person (at the
Fig. 1 Recruitment and data collection
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hospital). Time 1 data collection will take no longer than
30 min to complete and will be conducted within 1 week
from referral/admission.
The research assistant will phone the family carer when
it is time to collect time 2 and 3 data and ask them if they
would prefer to complete the questionnaire over the
phone, in person at the hospital, or by post. Times 2 and 3
data collection will take no longer than 30 min to
complete.
If the family carer is in the intervention group, the
research assistant will refer them to the family meeting
facilitator (who has been trained to conduct the structured
family meetings) as soon as the carer has completed time1
data. Similarly, once the family meeting has been conducted
(ideally within a week of time 1 data being collected) the
family meeting facilitator will inform the research assistant.
This study design does not allow the research assistant to
be blinded to the condition to which carers are allocated.
If the family carer is in the control group, then they
receive usual care for the period between time 1 and
time 2 data collection.
Standard care
Standard care is known to be quite heterogeneous. Family
meetings are offered in all participating sites but the fre-
quency and method of conduct varies; thus we are mindful
that some control participants will receive a family meet-
ing, although these are typically not formally structured.
Our research has been designed in recognition of this and
we will also collect data on the frequency of family meet-
ings conducted in the control group.
Intervention
The intervention which is administered according to clin-
ical guidelines for conducting family meetings is compre-
hensively outlined in the earlier work of Hudson and
colleagues [32]. In summary, the guidelines incorporate: (1)
principles for conducting family meetings; (2) pre-meeting
procedures such as liaising with the patient/family and
prioritising issues; (3) deciding who needs to attend the
family meeting; (4) a procedure for conducting the meeting;
and (5) strategies for follow up after the meeting, including
data on whether or not the priority issues for the family
carer have been addressed. The meetings are intended to
take no longer than one hour.
Approximately four facilitators will be appointed at each
of the participating sites to convene and conduct the fam-
ily meeting/intervention. The facilitators will be nurses,
doctors, social workers or psychologists with extensive
clinical palliative care experience and relevant academic
qualifications. Facilitators will be identified by the director
of palliative care at each of the participating sites. They
will receive training in administering the intervention
which will incorporate conducting the family meeting
according to the aforementioned guidelines; along with
communications skills theory and practicum. In order to
limit variation of intervention delivery at each site the
training approach for all facilitators will be consistent and
will be conducted face to face over the course of 1 day.
Data collection
Eligibility data will be recorded along with reasons for re-
fusal to participate (for those eligible who are willing to
provide this information). Data collection will involve
mixed methods including quantitative and qualitative data.
Family carer measures We have administered similar
quantity and type of measures to family caregivers with
no negative sequelae apparent [33].
(1)The 12 item version of General Health Questionnaire
(GHQ) [34]. The GHQ has demonstrated good
reliability and validity and is commonly used as a
screening tool to detect those likely to develop
psychiatric disorders. It is a measure of the common
mental health problems including the domains of
depression, anxiety, somatic symptoms and social
withdrawal [35, 36]. The GHQ is scored on a Likert
scale, with a maximum score of 36; score ≥15
indicates evidence of distress; and score >20 suggests
severe problems and psychological distress. Family
carers who meet the cut off for profound
psychological distress (>20) at T1 will be advised of
such and recommended that they seek formal
medical/psychological review from their treating
doctor or palliative care team. They will however still
be eligible to participate in the study. GHQ will be
administered at all three time points.
(2)The Family Inventory of Needs (FIN) [37] has 20
items and has been shown to have good reliability and
validity [37, 38] . Administered at times 1 and 2 only
as this focuses on caregiving while the patient is alive.
(3)The Preparedness for Caregiving Scale (PCS) [39]
has 8 items and has been shown to have good
reliability and validity [38] . Administered at times 1
and 2 only as this measure focuses on caregiving
while the patient is alive.
(4)The Short form health survey version 2 (SF12-v2) is
12 items quality of life measure that has been widely
used across many diverse populations. It is a
measure of both physical and emotional quality of
life [40]. Administered at all three time points.
(5)The Caregiver Quality of Life Index-Cancer (CQOLC)
scale is a measure of caregiver quality of life. The scale
has been found to be a reliable and valid measure of
quality of life for caregivers of cancer patients and
cancer patients receiving palliative care [41]. As the
questions do not specifically relate to cancer, they are
Hudson et al. BMC Palliative Care  (2015) 14:73 Page 5 of 9
appropriate for caregivers of non-cancer palliative care
patients. Administered at times 1 and 2 only as this
measure focuses on caregiving QOL while the patient
is alive.
(6)Family carers will also complete a socio-demographic
survey including details and level of function of their
relative via the Australian Karnofsky scale [42].
Administered at T1 only.
(7)At time 3 (after death) the family carer will also
complete a measure of the quality of the death which
will be measured using a shortened version of the
Quality of Death and Dying Questionnaire [43, 44].
This measure has been widely used with similar
populations and includes 17 items that measure
different aspects of the dying experience.
We will also collect data on the date of patients’ death
to assist with determining the impact of having the family
meeting further away from death.
File audit (Patient record) For the second hypothesis
(H2), data will be collected from the patients’ medical
records using a File Audit Checklist and also from data
from the hospital administrative data sets (which include
ICD-10-AM codes which are collected for the Department
of Health). These data will include indicators of quality
end-of-life care [45]: hospital admissions and length of stay,
ED presentations, hours in ICU, chemotherapy administra-
tion in the last 30 and 14 days of life, a new regimen of
chemotherapy in last 30 days of life, and place of death.
Data will also be collected on access to supportive care
services, evidence of advanced care plans, and attendance
at family meetings.
Sample size, power calculation and feasibility
The primary outcome for H1 is measured via the GHQ, a
12-item scale with a possible range of 0-36. Our previous
study [46] of 275 family carers in which the mean GHQ
difference was 2.8 (SD = 5.6), represents a medium effect
size (ES) of 0.5 which is a common estimate of a minimal
important difference [47]. The sample size calculations are
based on a smaller mean difference between groups of 2.4,
as some carers in the control group will have family meet-
ings as part of standard care. Estimated sample size for
two-sample comparison of means Test Ho: m1 =m2,
where m1 is the mean in population 1and m2 is the mean
in population 2 is 97 per group (total n = 194). This calcu-
lation assumes that alpha = .05 (two sided), power = .90
(90 %), m1 = 16.8, m2-14, sd1 = 6, sd2 = 6, n2/n1 = 1.00.
This sample size allows for sub-group analyses of the con-
sult service compared to the inpatient service or other
similar sub-group analysis.
For the three recruitment sites, we have approximately
1900 palliative care inpatient admissions per year and
3000 palliative care consult service admissions per year.
However, many consult service admissions become in-
patient admissions. Approximately a third of the total
admissions per year would be both consult admissions and
inpatient admissions, leaving 3280 admissions per year that
reflect separate individuals. Based on eligibility rates and
response rates of similar previous studies we can assume
50 % of these are eligible (n = 1640), ineligibility mostly due
to being imminently dying. A further 33 % of those who
are eligible consent to participate (n = 546). Of the 546 that
consent, we assume that 60 % will complete data collection
at Time 1 (n = 327). Assuming 30 % attrition at T2 (leaving
n = 228) and 50 % attrition at T3 (since it is during
bereavement, attrition may be quite high), 114 cases can be
completed per year, providing the required sample size of
228 from the recruitment pool in 2 years.
Ethical considerations
Ethical clearance has been obtained at each of the partici-
pating hospitals: St Vincent’s Hospital Melbourne, Austin
Health, Melbourne Health - Australia. The trial has also
been registered with the Australian New Zealand Clinical
Trials Group ACTRN12615000200583.
Analyses plan
The main analyses will be performed on pooled data
across sites for the intervention and control groups, fol-
lowing an analysis of the baseline data to identify any
differences between sites. We will undertake analyses as
follows. Summary statistics will be calculated to compare
the characteristics of carers in each group. Linear mixed
models will be used to (1) compare patterns of change
over time by testing the intervention group by time inter-
action and (2) estimating and testing differences in scores
between groups at T2 and at T3 via linear contrasts, and
accounting for the non-independent nature of the data in
clusters. Mixed models yield unbiased estimates for data
which are missing [48], and is relevant for cluster trials
[49]. Sub analyses will be undertaken dependant upon
obtaining a suitable sample size. In the event of ‘no inter-
vention effect’, where possible, a sub-analysis will be con-
ducted to compare outcomes in the control group carers
who did not have a meeting (i.e. a ‘per protocol’ analysis)
with those in the intervention group carers who had a
meeting. In the event of ‘no intervention effect’, a sub-
analysis will be conducted on those that were moderately
or highly distressed at time 1 to compare outcomes in the
control group and intervention group for distressed
carers. A sub analysis will also be undertaken to explore
any differences in outcomes between participants re-
cruited from the specialist palliative care in-patient facility
and those recruited from a palliative care hospital consult-
ancy service.
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Aim 2
To determine the cost-benefit and resource implications
of implementing SFM meetings into routine practice.
Health economic modeling will be applied to estimate
the cost-benefit of SFM. Decision analysis [50] will be used
to compare the downstream consequences of SFM versus
standard of care, by extrapolation of efficacy data from the
trial. The incorporation of Markov [51] and life-tabling
[52] techniques will allow for the modeling of outcomes
beyond the duration of the trial. The key output in cost-
benefit analyses is net costs, comprising the costs of SFM
minus costs saved from the reduction in downstream
health services utilisation. Only direct healthcare costs will
be measured, and from the perspective of the Australian
healthcare system. These will predominantly be costs of
inpatient and outpatient hospital care, medications and
community-based healthcare services. All health economic
analyses will be undertaken in accordance with recom-
mended approaches, such as 5 % discounting of estimated
future costs and health gains. To account for any uncer-
tainty in the data, inputs for health economic modeling,
sensitivity and uncertainty analyses will be undertaken via
Monte Carlo simulation [53].
We will also conduct a process evaluation to determine
the resource requirements of administering the SFM. Such
data will include the mean time to conduct the interven-
tion, the number and the types of health disciplines
involved in the family meeting and whether or not the
patient also participated. We will also explore the adminis-
trative time involved in setting up and facilitating the SFM.
At the completion of the intervention phase two focus
groups will be conducted with health professionals and
interviews (approx. 20) with family carers from the inter-
vention sites will be undertaken to explore the perceived
impacts and benefits of the SFMs. They will also be used
to discern external and internal policy changes; clinician
(staff resource, beliefs and attitudes), patient and carer
factors (access, timeliness, understanding, information).
This will assist with monitoring temporal issues relevant
to the study.
All health professionals at each of the two intervention
sites who have attended at least two of the SFMs will be
invited to participate in a focus group (via a personalised
email). The Plain Language Statement and consent form
will be attached to the email. At the beginning of the
focus group, the project officer will go through the Plain
Language Statement; which will provide all potential
participants with the assurance that their involvement is
entirely voluntary and their participation or otherwise
will in no way hinder their employment. Health profes-
sionals will be asked to complete the consent form. Once
informed consent is obtained from the palliative care health
professionals, the project officer will conduct a focus group.
The focus group will be taped and transcribed and any
identifying information deleted from the transcripts. The
focus group will take about 30–60 min.
One in six family carers who complete the intervention
will be invited to participate in an interview after the com-
pletion of their time 2 questionnaires via a question on the
questionnaire with a Yes/No response format and an open-
ended space which requests a phone number and best time
to call. The research assistant will then call the family carer
at the suggested time and ask the carer whether they are
still interested in participating in an interview and if they
are, they will organise a convenient time. Interviews may
be conducted at the hospital or over the telephone. Inter-
views will be recorded and transcribed. A semi structured
interview guide has been developed by the project team
and incorporates questions related to: perceptions of the
way the family meeting was convened and conducted; re-
flections on any positive or negative outcomes and recom-
mendations for improving family meetings. It is expected
that the interview take approximately 30 min.
Focus groups will be recorded and transcribed and ana-
lysed for impacts, benefits and additional content. Inter-
views will be recorded digitally verbatim and transcribed.
NVivo software will be used to assist with storage and
coding. The interviews will be analysed using the five steps
of thematic analysis recommended by Boyatzi [54] (1)
reducing the raw information, (2) creating a code, (3)
determining the reliability of the code, (4) identifying
themes within subthemes and (5) comparing themes
across subsamples. The first two interviews (20 %) from
each site will be coded by two members of the research
team. A Kappa value of 0.6–0.8 indicating substantial
agreement between raters [55] will be achieved at step 3
prior to the research assistants completing steps 4 and 5
for the remainder of the interviews.
Study fidelity
One in six intervention meetings at each site will be se-
lected for transcription and analysis to check fidelity of the
intervention delivery method; and we will also record infor-
mation about the attendees and topics discussed and later
(a subsequent study) analyse the recordings with respect to
a range of factors including the process of communication
between the carer, patient and health professionals. Under-
standing the content and dynamics of family meetings will
further inform implementation.
Discussion
The WHO advocates that palliative care should not only
improve the quality of life for patients but also for their
families [3]. The principle of family centred care and the
inclusion of family carer satisfaction with end-of-life
health care is advocated as a key indicator of hospital
performance [56]. Current guidelines advocate family
meetings to be routinely conducted for all patients [28]
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which has major financial and resource implications.
These encounters however are typically not consistently
provided nor are they conducted according to best available
evidence. The research described herewith will determine
whether SFMs have positive practical and psychological on
the family, impacts on health service usage, and financial
benefits to the health care sector. This study will also
provide clear guidance on appropriate timing in the
disease/care trajectory to provide a family meeting.
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